Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy

Details werden geladen...

Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy - BioSpace

Sangamo Therapeutics will lay off 51 members of its workforce while retaining 77 people to continue work on the programs central to Astellas and Eli Lilly's bids.

Gene Editing Pioneer Sangamo Files for Chapter 11 Bankruptcy; Agrees to Sell Assets

How To Shine As Biotech Comes Back From the Brink - BioSpace

Camp Mystic in Texas files for bankruptcy after catastrophic floods killed 28 people - Los Angeles Times

Beam one-ups Wave as both show promise of genetic editing for AATD - BioSpace

Meta layoffs: Employees told to work from home as countdown begins for 4AM emails, leaked memo from HR chief says: 'We're now at the stage where…'

Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy - BioSpace

Gene Editing Pioneer Sangamo Files for Chapter 11 Bankruptcy; Agrees to Sell Assets

How To Shine As Biotech Comes Back From the Brink - BioSpace

Camp Mystic in Texas files for bankruptcy after catastrophic floods killed 28 people - Los Angeles Times

Beam one-ups Wave as both show promise of genetic editing for AATD - BioSpace

Meta layoffs: Employees told to work from home as countdown begins for 4AM emails, leaked memo from HR chief says: 'We're now at the stage where…'